Megalotect 100 E/ml The Netherlands
Megalotect 100 E/ml is indicated for the prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.
It is an immunoglobulin preparation from plasma of donors with a high antibody titer against the cytomegalovirus. It has a distribution of IgG subclasses closely proportional to that in native human plasma.
MegMegalotect 100 E/ml is a solution for infusion and is sold in injection vials of 10 ml and 50 ml.
Megalotect 100 E/ml is a prescription only drug distributed by TwinPharma BV in the Netherlands. Biotest AG is the registration holder.
Hepatect CP contains mainly IgG with a specifically high content of antibodies against hepatitis B virus surface antigen.
Megalotect 100 E/ml
Megalotect 100 E/ml is an immunoglobulin preparation from plasma of donors with a high antibody titer against the cytomegalovirus.
Prevention of hepatitis B virus re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver failure.
Interim & advice
Open positions, replacement or extra activities? TwinPharma can offer a solution.